Home LiteratureArticle Details
PMID: 1703324 Published · ppublish English Journal Article

Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist.

Science (New York, N.Y.) ·Vol. 251 ·No. 4992 ·1991-01-25 ·Pages 437-9

McLean S, Ganong AH, Seeger TF, Bryce DK, Pratt KG, Reynolds LS, Siok CJ, Lowe JA, Heym J

Abstract

CP-96,345, a nonpeptide substance P antagonist, is selective for the tachykinin NK1 receptor. The compound binds to a single population of sites in guinea pig brain and potently inhibits substance P-induced excitation of locus ceruleus neurons. CP-96,345 should be a useful tool for studying the action of substance P in the central nervous system.

MeSH Terms
Action Potentials Animals Autoradiography Binding Sites Binding, Competitive Biphenyl Compounds/metabolism,pharmacology Brain/diagnostic imaging,metabolism Corpus Striatum/diagnostic imaging,metabolism Guinea Pigs Hydrogen-Ion Concentration Male Radionuclide Imaging Receptors, Neurokinin-1 Receptors, Neurotransmitter/antagonists & inhibitors,metabolism Receptors, Tachykinin Spectrophotometry Substance P/metabolism Tachykinins/metabolism
Chemicals
Biphenyl Compounds Receptors, Neurokinin-1 Receptors, Neurotransmitter Receptors, Tachykinin Tachykinins Substance P CP 96345
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
McLean S
Department of Neuroscience, Central Research Division, Pfizer Inc., Groton, CT 06340.
Ganong A H
Seeger T F
Bryce D K
Pratt K G
Reynolds L S
Siok C J
Lowe J A
Heym J
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1991-01-25
Pages
437-9
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com